Oruka Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Oruka Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Oruka Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $938K, a 251% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $938K +$671K +251% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $8K -$285K -97.3% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $17K -$301K -94.7% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $247K -$96K -28% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $267K -$100K -27.2% Sep 30, 2023 10-Q 2023-10-18
Q2 2023 $293K -$98K -25.1% Jun 30, 2023 10-Q 2023-07-21
Q1 2023 $318K -$96K -23.2% Mar 31, 2023 10-Q 2023-04-24
Q4 2022 $343K -$94K -21.5% Dec 31, 2022 10-K 2024-02-01
Q3 2022 $367K -$93K -20.2% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $391K -$91K -18.9% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $414K $0 0% Mar 31, 2022 10-Q 2022-05-02
Q4 2021 $437K +$9K +2.1% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $460K Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $482K +$458K +1908% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $414K +$365K +745% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $428K +$406K +1845% Dec 31, 2020 10-K 2022-03-14
Q2 2020 $24K -$4K -14.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $49K +$5K +11.4% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $22K Dec 31, 2019 10-K 2021-03-18
Q3 2019 $11K Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $28K Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $44K Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.